Jorge Del Rio-Martinez
Ciudad Real, CM, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Cardiac amyloidosis and red flags: natural history and its impact in morbimortality
Journal: Medicina clinica
Published: June 16, 2024
Intermediate-effect size p.Arg637Gln in FHOD3 increases risk of HCM and is associated with an aggressive phenotype in homozygous carriers.
Journal: Journal of medical genetics
Published: May 22, 2023
Usefulness of risk scores and predictors of atrial fibrillation recurrence after elective electrical cardioversion.
Journal: Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc
Published: May 20, 2023
Development and Validation of a Prediction Model and Score for Transthyretin Cardiac Amyloidosis Diagnosis: T-Amylo.
Journal: JACC. Cardiovascular imaging
Published: December 28, 2022
Starting sacubitril-valsartan is safe in patients with transthyretin cardiac amyloidosis and impaired ejection fraction.
Journal: Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology
Published: December 22, 2022
Cardiovascular events after COVID-19 hospitalization: long-term follow-up
Journal: Revista espanola de cardiologia
Published: August 02, 2021
Cardiovascular events after COVID-19 hospitalization: long-term follow-up.
Journal: Revista espanola de cardiologia (English ed.)
Published: July 15, 2021
Cardiovascular disease after COVID-19 infection in elderly patients. Results of annual follow-up of a cohort of survivors
Journal: Revista espanola de geriatria y gerontologia
Published: June 07, 2021
Mortality and associated prognostic factors in elderly and very elderly hospitalized patients with respiratory disease COVID-19
Journal: Revista espanola de geriatria y gerontologia
Published: July 13, 2020
Comparative analysis between the use of renin-angiotensin system antagonists and clinical outcomes of hospitalized patients with COVID-19 respiratory infection.
Journal: Medicina clinica (English ed.)
Published: June 13, 2020
Comparative analysis between the use of renin-angiotensin system antagonists and clinical outcomes of hospitalized patients with COVID-19 respiratory infection
Journal: Medicina clinica
Published: June 13, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026